Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Anticoagulant Options for Atrial Fibrillation

Evidence-Based Hierarchy of Options

  • The American College of Cardiology strongly recommends against antiplatelet therapy alone (including aspirin monotherapy) for stroke prevention in atrial fibrillation patients, regardless of stroke risk 2
  • Aspirin offers minimal protection with only 19% stroke reduction (95% CI 2% to 34%) in atrial fibrillation patients 1
  • Aspirin is more effective at preventing nondisabling strokes rather than disabling cardioembolic strokes, which are the most dangerous type in atrial fibrillation 1
  • Aspirin may have slightly better efficacy in patients with hypertension or diabetes 1
  • Aspirin plus clopidogrel provides 28% relative risk reduction compared to aspirin alone, but comes with 57% relative increase in major bleeding 3, 4
  • This combination is inferior to warfarin for stroke prevention (42% relative risk reduction favoring warfarin) with similar major bleeding rates 3, 4, 5

Critical Clinical Caveat

  • While aspirin is the cheapest option, it should NOT be used for stroke prevention in atrial fibrillation patients who are eligible for oral anticoagulation, as the modest benefit does not justify choosing it over more effective options when anticoagulation is indicated 1, 2